Mechanisms by which heme oxygenase rescue renal dysfunction in obesity

Redox Biology

Volumn 2, Issue , 2014, Pages 1029-1037

  Ndisang, Joseph Fomusi ^a   Tiwari, Shuchita ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Beta catenin; CD2 associated protein; Heme oxygenase; Oct 3 4; Podocalyxin; Podocin

Indexed keywords

8 ISOPROSTANE; BETA CATENIN; CD2 ASSOCIATED PROTEIN; HEME OXYGENASE; HEME OXYGENASE 1; HEMIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEPHRIN; OCTAMER TRANSCRIPTION FACTOR 4; ORGANIC CATION TRANSPORTER 3; PODOCALYXIN; PODOCIN; STANNSOPORFIN; TRANSCRIPTION FACTOR PAX2; WT1 PROTEIN; HMOX1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME MECHANISM; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY HYPERTROPHY; KIDNEY TUBULE DISORDER; MALE; MULTINUCLEAR CELL; NEPHRITIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PODOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEINURIA; RAT; RENAL PROTECTION; ZUCKER RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOLOGY;

ANIMALS; HEME OXYGENASE (DECYCLIZING); HEMIN; KIDNEY; KIDNEY DISEASES; MALE; OBESITY; RATS; RATS, ZUCKER;

EID: 84908567134     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2014.09.001     Document Type: Article

References (41)

1. Krmar R.T., Bárány P. Chronic kidney disease: obesity in children with end-stage renal disease. Nature Reviews. Nephrology 2013, 9:707-708. http://www.ncbi.nlm.nih.gov/pubmed/24145321, 10.1038/nrneph.2013.223.
2. Satirapoj B., Supasyndh O., Mayteedol N., Punpanich D., Chaiprasert A., Nata N., Ruangkanchanasetr P., Kanjanakul I., Choovichian P. Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives. Nephrology 2013, 18:229-234. http://www.ncbi.nlm.nih.gov/pubmed/23279639, 10.1111/nep.12023.
3. Nugent R.A., Fathima S.F., Feigl A.B., Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron. Clinical Practice 2011, 118:c269-c277. http://www.ncbi.nlm.nih.gov/pubmed/21212690, 10.1159/000321382.
4. Murray C.J., Richards M.A., Newton J.N., Fenton K.A., Anderson H.R., Atkinson C., Bennett D., Bernabé E., Blencowe H., Bourne R., Braithwaite T., Brayne C., Bruce N.G., Brugha T.S., Burney P., Dherani M., Dolk H., Edmond K., Ezzati M., Flaxman A.D., Fleming T.D., Freedman G., Gunnell D., Hay R.J., Hutchings S.J., Ohno S.L., Lozano R., Lyons R.A., Marcenes W., Naghavi M., Newton C.R., Pearce N., Pope D., Rushton L., Salomon J.A., Shibuya K., Vos T., Wang H., Williams H.C., Woolf A.D., Lopez A.D., Davis A. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013, 381:997-1020. http://www.ncbi.nlm.nih.gov/pubmed/23668584, 10.1016/S0140-6736(13)60355-4.
5. Briffa J.F., McAinch A.J., Poronnik P., Hryciw D.H. Adipokines as a link between obesity and chronic kidney disease. American Journal of Physiology. Renal Physiology 2013, 305:F1629-F1636. http://www.ncbi.nlm.nih.gov/pubmed/24107418, 10.1152/ajprenal.00263.2013.
6. Navarro-González J.F., Mora-Fernández C., Muros de Fuentes M., García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature Reviews. Nephrology 2011, 7:327-340. http://www.ncbi.nlm.nih.gov/pubmed/21537349, 10.1038/nrneph.2011.51.
7. Lo D.J., Weaver T.A., Kleiner D.E., Mannon R.B., Jacobson L.M., Becker B.N., Swanson S.J., Hale D.A., Kirk A.D. Chemokines and their receptors in human renal allotransplantation. Transplantation 2011, 91:70-77. http://www.ncbi.nlm.nih.gov/pubmed/21441854, 10.1097/TP.0b013e3181fe12fc.
8. Singh D.K., Winocour P., Farrington K. Oxidative stress in early diabetic nephropathy: fueling the fire. Nature Reviews. Endocrinology 2011, 7:176-184. http://www.ncbi.nlm.nih.gov/pubmed/21151200, 10.1038/nrendo.2010.212.
9. Marshall S.M. The podocyte: a potential therapeutic target in diabetic nephropathy?. Current Pharmaceutical Design 2007, 13:2713-2720. http://www.ncbi.nlm.nih.gov/pubmed/17897015, 10.2174/138161207781662957.
10. Menne J., Meier M., Park J.K., Boehne M., Kirsch T., Lindschau C., Ociepka R., Leitges M., Rinta-Valkama J., Holthofer H., Haller H. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney International 2006, 70:1456-1462. http://www.ncbi.nlm.nih.gov/pubmed/16955103, 10.1038/sj.ki.5001830.
11. Satchell S.C., Tooke J.E. What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?. Diabetologia 2008, 51:714-725. http://www.ncbi.nlm.nih.gov/pubmed/18347777, 10.1007/s00125-008-0961-8.
12. Nakatsue T., Koike H., Han G.D., Suzuki K., Miyauchi N., Yuan H., Salant D.J., Gejyo F., Shimizu F., Kawachi H. Nephrin and podocin dissociate at the onset of proteinuria in experimental membranous nephropathy. Kidney International 2005, 67:2239-2253. http://www.ncbi.nlm.nih.gov/pubmed/15882266, 10.1111/j.1523-1755.2005.00328.x.
13. Wang Y., Wang D.H. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension. Molecular Medicine 2011, 17:1204-1212. http://www.ncbi.nlm.nih.gov/pubmed/21792478, 10.2119/molmed.2011.00063.
14. Ndisang J.F. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators of Inflammation 2010, 2010:359732. http://www.ncbi.nlm.nih.gov/pubmed/20508722, 10.1155/2010/359732.
15. Ndisang J.F., Jadhav A., Mishra M. The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in Zucker diabetic fatty rats. PloS One 2014, 9:e87936. http://www.ncbi.nlm.nih.gov/pubmed/24498225, 10.1371/journal.pone.0087936.
16. Ndisang J.F., Jadhav A. Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis. Endocrinology 2014, 155:215-229. http://www.ncbi.nlm.nih.gov/pubmed/24140713, 10.1210/en.2013-1050.
17. Ndisang J.F., Jadhav A. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. Journal of Pharmacology and Experimental Therapeutics 2010, 334:87-98. http://www.ncbi.nlm.nih.gov/pubmed/20392817, 10.1124/jpet.109.164871.
18. Jadhav A., Torlakovic E., Ndisang J.F. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. American Journal of Physiology. Renal Physiology 2009, 296:F521-F534. http://www.ncbi.nlm.nih.gov/pubmed/19116243, 10.1152/ajprenal.00510.2007.
19. Heneidi S., Simerman A.A., Keller E., Singh P., Li X., Dumesic D.A., Chazenbalk G. Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue. PloS One 2013, 8:e64752. http://www.ncbi.nlm.nih.gov/pubmed/23755141, 10.1371/journal.pone.0064752.
20. Villanueva S., Carreño J.E., Salazar L., Vergara C., Strodthoff R., Fajre F., Céspedes C., Sáez P.J., Irarrázabal C., Bartolucci J., Figueroa F., Vio C.P. Human mesenchymal stem cells derived from adipose tissue reduce functional and tissue damage in a rat model of chronic renal failure. Clinical Science 2013, 125:199-210. 10.1042/CS20120644.
21. Sodhi K., Puri N., Kim D.H., Hinds T.D., Stechschulte L.A., Favero G., Rodella L., Shapiro J.I., Jude D., Abraham N.G. PPARdelta binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats. International Journal of Obesity 2014, 38:456-465. http://www.ncbi.nlm.nih.gov/pubmed/23779049, 10.1038/ijo.2013.116.
22. Zhang J., Pippin J.W., Krofft R.D., Naito S., Liu Z.H., Shankland S.J. Podocyte repopulation by renal progenitor cells following glucocorticoids treatment in experimental FSGS. American Journal of Physiology. Renal Physiology 2013, 304:F1375-F1389. http://www.ncbi.nlm.nih.gov/pubmed/23486009, 10.1152/ajprenal.00020.2013.
23. Watanabe N., Kato M., Suzuki N., Inoue C., Fedorova S., Hashimoto H., Maruyama S., Matsuo S., Wakamatsu Y. Kidney regeneration through nephron neogenesis in medaka. Development, Growth & Differentiation 2009, 51:135-143. http://www.ncbi.nlm.nih.gov/pubmed/19207184, 10.1111/j.1440-169X.2009.01090.x.
24. Jadhav A., Ndisang J.F. Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension. Experimental Biology and Medicine 2009, 234:764-778. http://www.ncbi.nlm.nih.gov/pubmed/19429856, 10.3181/0810-RM-302.
25. Ndisang J.F., Jadhav A. Upregulating the heme oxygenase system suppresses left ventricular hypertrophy in adult spontaneously hypertensive rats for 3 months. Journal of Cardiac Failure 2009, 15:616-628. http://www.ncbi.nlm.nih.gov/pubmed/19700139, 10.1016/j.cardfail.2009.02.003.
26. Salley T.N., Mishra M., Tiwari S., Jadhav A., Ndisang J.F. The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes. PloS One 2013, 8:e79270. http://www.ncbi.nlm.nih.gov/pubmed/24260182, 10.1371/journal.pone.0079270.
27. Jadhav A., Ndisang J.F. Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of human primary aldosteronism. Free Radical Biology & Medicine 2012, 53:2277-2286. http://www.ncbi.nlm.nih.gov/pubmed/23089228, 10.1016/j.freeradbiomed.2012.10.529.
28. Jadhav A., Tiwari S., Lee P., Ndisang J.F. The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. Journal of Pharmacology and Experimental Therapeutics 2013, 345:239-249. http://www.ncbi.nlm.nih.gov/pubmed/23442249, 10.1124/jpet.112.200808.
29. Tiwari S., Mishra M., Jadhav A., Gerger C., Lee P., Weber L., Ndisang J.F. The risk of heart failure and cardiometabolic complications in obesity may be masked by an apparent healthy status of normal blood glucose. Oxidative Medicine and Cellular Longevity 2013, 2013:253657. http://www.ncbi.nlm.nih.gov/pubmed/24454978, 10.1155/2013/253657.
30. Ndisang J.F., Wang R. Age-related alterations in soluble guanylyl cyclase and cGMP pathway in spontaneously hypertensive rats. Journal of Hypertension 2003, 21:1117-1124. http://www.ncbi.nlm.nih.gov/pubmed/12777948, 10.1097/00004872-200306000-00011.
31. Ndisang J.F., Lane N., Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 2009, 150:2098-2108. http://www.ncbi.nlm.nih.gov/pubmed/19106228, 10.1210/en.2008-0239.
32. Ndisang J.F., Lane N., Jadhav A. Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. Journal of Hypertension 2008, 26:1188-1199. http://www.ncbi.nlm.nih.gov/pubmed/18475157, 10.1097/HJH.0b013e3282fad93d.
33. Delanty N., Reilly M.P., Pratico D., Lawson J.A., McCarthy J.F., Wood A.E., Ohnishi S.T., Fitzgerald D.J., FitzGerald G.A. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997, 95:2492-2499. http://www.ncbi.nlm.nih.gov/pubmed/9184579, 10.1161/01.CIR.95.11.2492.
34. Ndisang J.F., Jadhav A. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 2009, 150:2627-2636. http://www.ncbi.nlm.nih.gov/pubmed/19228889, 10.1210/en.2008-1370.
35. Ndisang J.F., Lane N., Jadhav A. Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. American Journal of Physiology. Endocrinology and Metabolism 2009, 296:E1029-E1041. http://www.ncbi.nlm.nih.gov/pubmed/19208858, 10.1152/ajpendo.90241.2008.
36. Finegood D.T., McArthur M.D., Kojwang D., Thomas M.J., Topp B.G., Leonard T., Buckingham R.E. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001, 50:1021-1029. http://www.ncbi.nlm.nih.gov/pubmed/11334404, 10.2337/diabetes.50.5.1021.
37. Kuhlmann J., Neumann-Haefelin C., Belz U., Kalisch J., Juretschke H.P., Stein M., Kleinschmidt E., Kramer W., Herling A.W. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes 2003, 52:138-144. http://www.ncbi.nlm.nih.gov/pubmed/12502504, 10.2337/diabetes.52.1.138.
38. Ndisang J.F., Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. American Journal of Physiology. Endocrinology and Metabolism 2009, 296:E829-E841. http://www.ncbi.nlm.nih.gov/pubmed/19190261, 10.1152/ajpendo.90783.2008.
39. Ndisang J.F., Jadhav A. The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 2010, 298:R211-R223. http://www.ncbi.nlm.nih.gov/pubmed/19864334, 10.1152/ajpregu.91000.2008.
40. Ndisang J.F., Lane N., Syed N., Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 2010, 151:549-560. http://www.ncbi.nlm.nih.gov/pubmed/20016031, 10.1210/en.2009-0471.
41. Ndisang J.F. The heme oxygenase system selectively modulates proteins implicated in metabolism, oxidative stress and inflammation in spontaneously hypertensive rats. Current Pharmaceutical Design 2014, 20:1318-1327. http://www.ncbi.nlm.nih.gov/pubmed/23978103, 10.2174/13816128113199990551.